Business
Spears Business honors 2020 grad students
The Spears School of Business held a special event Nov. 20 in recognition of graduate students who are scheduled to received advanced degrees in at the end of the fall 2020 semester. The acknowledgement, held at the ConocoPhillips OSU Alumni Center, honored business graduate students from nine master’s degree and doctorate programs who will not be able to participate in traditional commencement ceremonies this year because of the COVID-19 pandemic.
Recent News
A number of Oklahoma State University students were recently awarded more than $10,000 in scholarships while competing in the 2020 Virtual Pitch and Poster competition hosted by the Riata Center for Entrepreneurship.
The Spears School of Business held a special celebration Nov. 13 at the Business Building on the Oklahoma State University campus marking the graduation of 2020 undergraduate business students and featured Spears Business Dean Ken Eastman congratulating each graduate.
A catalyst for the rise of Oklahoma State football and a presence at every Cowboy home game for years, the legendary Boone Pickens will be permanently honored with a statue at the stadium that bears his name.
The Oklahoma State University Robert M. Kerr Food and Agricultural Products Center and the Oklahoma Small Business Development Center are working together to support entrepreneurial and small businesses in the state.
Oklahoma State University’s Spears School of Business has announced that four distinguished alumni – Karl Bovee, Lucina and Kyle Thompson, and Shane Wharton – will be inducted into the school’s Hall of Fame for 2020 in a ceremony to take place in 2021.
An analysis of digital health records from thousands of COVID-19 patients admitted to hospitals around the country has led to the development of technology to predict the risk of death for those with COVID. Researchers at the Oklahoma State University Center for Health Systems Innovation (CHSI) in Tulsa and Stillwater are using digital health data to build predictive models of disease risk that could improve treatment and outcomes.